Filing Overview
This Form 8-K was filed by Blue Water Biotech, Inc. (the source metadata identifies the company as Onconetix, Inc.; the filing itself names Blue Water Biotech, Inc.). The report’s earliest reported event date was September 2, 2023, and it was signed and dated September 8, 2023. The company’s common stock traded under the symbol BWV on Nasdaq.
Material Corporate Event
Effective September 2, 2023, Vuk Jeremić resigned from the company’s Board of Directors and from the Compensation Committee and Nominating and Corporate Governance Committee.
The filing states that the resignation was not due to any disagreement with management or the Board concerning the company’s operations, policies, or practices.
Financial Information
This filing does not provide financial statements or clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Outlook, Risks, and Unusual Items
No guidance, operating outlook, contingencies, or additional risk commentary is provided. The principal disclosed item is the director and committee resignation.
Investor Verification Items
- Verify the registrant’s identity, because the supplied metadata refers to Onconetix, Inc., while the filing names Blue Water Biotech, Inc.
- Assess the effect of the board and committee resignation on governance, committee composition, and oversight.
- Review subsequent filings for replacement directors, committee reassignments, or related corporate changes.
- Confirm that no disagreement or other undisclosed circumstances accompanied the resignation.